| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 25 | REGN Regeneron Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 166 | 0.00 | 1,559 |
| 2 Jan 25 | REGN Regeneron Pharmaceuticals | NQSO Common Stock | Grant | Acquire A | No | No | 719.37 | 1,958 | 1.41 mm | 1,958 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 10,290 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 15,638 | 0.00 | 10,290 |
| 1 Aug 24 | CERE Cerevel Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 46,322 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0 | 4,809,418 | 0.00 | 0 |
| 1 Jul 24 | CERE Cerevel Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 41.1814 | 25,000 | 1.03 mm | 25,928 |
| 1 Jul 24 | CERE Cerevel Therapeutics | Common Stock | Option exercise | Acquire M | No | Yes | 3.5 | 25,000 | 87.50 k | 50,928 |
| 1 Jul 24 | CERE Cerevel Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 3.5 | 25,000 | 87.50 k | 2,177,417 |
| 5 Jun 24 | CERE Cerevel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 10,290 | 0.00 | 25,928 |
